VKH
DMK

Virtu KCG Holdings’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Virtu KCG Holdings’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$200K Buy
550
+279
+103% +$83.5K 0.01% 2165
2017
Q1 		$80K Buy
+271
New +$68.4K ﹤0.01% 2744
2016
Q4 		– Sell
-1,310
Closed -$315K – 3895
2016
Q3 		$315K Buy
1,310
+960
+274% +$200K 0.01% 1875
2016
Q2 		$69K Buy
+350
New +$161K ﹤0.01% 2617
2015
Q4 		– Sell
-146
Closed -$40K – 4039
2015
Q3 		$40K Buy
+146
New +$40.7K ﹤0.01% 3043
2015
Q1 		– Sell
-228
Closed -$99K – 4024
2014
Q4 		$99K Buy
+228
New +$72.4K ﹤0.01% 3224

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
LCM
Leisure Capital Management Costa Mesa, California $320M AUM 39.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SGS
Sterling Global Strategies Carlsbad, California $18M AUM 11.58% 1-Year Est. Return

Virtu KCG Holdings's DMK Position: Q2 2017 in Review

Virtu KCG Holdings increased its DMK Pharmaceuticals Corporation Common Stock (DMK) stake by 103% in Q2 2017, buying an estimated $83.5K and bringing the position to 550 shares worth $200K. The position accounts for 0.01% of the portfolio, ranked #2165.

Virtu KCG Holdings first reported a position in DMK in Q4 2014 and has held it in 6 quarters since. The position peaked at $315K in Q3 2016. 44 funds tracked by Wall St. Rank hold DMK as of Q2 2017.

  • Virtu KCG Holdings held 550 shares of DMK Pharmaceuticals Corporation Common Stock worth $200K as of Q2 2017.
  • Virtu KCG Holdings bought 279 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2017, an estimated $83.5K.
  • DMK Pharmaceuticals Corporation Common Stock made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2165 holding.
  • Virtu KCG Holdings first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2014 and has held it in 6 quarters since.
  • Virtu KCG Holdings's DMK Pharmaceuticals Corporation Common Stock position peaked at $315K in Q3 2016.
  • 44 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.